Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Hovnanian Enterprises Raises FY22 View To Rev $2.8B-$3B

– Dow Jones

byBenzinga Newsdesk

September 1, 2022

1 minute read

– Dow Jones

EF Hutton Initiates Coverage On Medalist Diversified REIT with Buy Rating, Announces Price Target of $1.5

By Benzinga Newsdesk

Today, 10:27 PM

EF Hutton analyst Gaurav Mehta initiates coverage on Medalist Diversified REIT (NASDAQ:MDRR) with a Buy rating and announces Price Target of $1.5.

MDRR

Amylyx Pharmaceuticals Announced FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALS

By Charles Gross

Today, 10:27 PM

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") announced today that the U.S.

AMLX

TD Securities Downgrades Louisiana-Pacific to Hold, Announces $72 Price Target

By Benzinga Newsdesk

Today, 10:27 PM

TD Securities analyst Sean Steuart downgrades Louisiana-Pacific (NYSE:LPX) from Buy to Hold and announces $72 price target.

LPX

Tuniu Q3 EPS $(0.03), Same YoY, Sales $10.90M Miss $24.95M Estimate

By Benzinga Newsdesk

Today, 10:27 PM

Tuniu (NASDAQ:TOUR) reported quarterly losses of $(0.03) per share. This is unchanged from the same period last year. The company reported quarterly sales of $10.90 million which missed the analyst consensus estimate of

TOUR

Hovnanian Enterprises Raises FY22 View To Rev $2.8B-$3B

Related Posts

EF Hutton Initiates Coverage On Medalist Diversified REIT with Buy Rating, Announces Price Target of $1.5

Amylyx Pharmaceuticals Announced FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALS

TD Securities Downgrades Louisiana-Pacific to Hold, Announces $72 Price Target

Tuniu Q3 EPS $(0.03), Same YoY, Sales $10.90M Miss $24.95M Estimate